CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis

Cutaneous leishmaniasis (CL) affects the lives of 0.7–1 million people every year causing lesions that take months to heal. These lesions can result in disfiguring scars with psychological, social and economic consequences. Antimonials are the first line of therapy for CL, however the treatment is l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Negl Trop Dis
Main Authors: Thacker, Seth G, McWilliams, Ian L., Bonnet, Beatrice, Halie, Lydia, Beaucage, Serge, Rachuri, Swaksha, Dey, Ranadhir, Duncan, Robert, Modabber, Farrokh, Robinson, Stephen, Bilbe, Graeme, Arana, Byron, Verthelyi, Daniela
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7075640/
https://ncbi.nlm.nih.gov/pubmed/32109251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0008050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados